New developments in the prospects for GLP‐1 therapy
Published in British Journal of Pharmacology
New developments in the prospects for GLP‐1 therapy
Is the C3a receptor antagonist SB290157 a useful pharmacological tool?
Published in British journal of pharmacology
Update on animal models for COVID-19 research.
Published in British journal of pharmacology
Risk factors, co‐morbidities, and co‐medications in cardioprotection: Importance for translation
Published in British Journal of Pharmacology
Novel approach for low-dose pulmonary delivery of hydroxychloroquine in COVID-19.
Published in British journal of pharmacology
Withdrawn: Dexamethasone resets the circadian clock in hippocampus via multiple mechanisms involving lithium-independent...
Published in British journal of pharmacology
The above article from British Journal of Pharmacology, published online as an Accepted Article on 19 August 2019 in Wiley Online Library (wileyonlinelibrary.com), has been withdrawn by agreement between the authors, the journal Editor-in-Chief Professor Amrita Ahluwalia, and John Wiley & Sons Limited. The withdrawal has been agreed owing to new fi...
Inhaled NO and COVID-19.
Published in British journal of pharmacology
ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020
...
Published in British Journal of Pharmacology
The many mechanisms of action of Chloroquine: to use or not to use (in COVID‐19) that is the question
Published in British Journal of Pharmacology
Therapeutic implications of the PP2A/MET signalling axis in doxorubicin‐induced cardiotoxicity and antitumour properties...
Published in British Journal of Pharmacology
